US generics business that accounts for nearly half of Sun Pharma sales grew at a moderate pace of 4 percent USD 507 million in the third quarter.
first published: Feb 14, 2017 03:25 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.